What does the Data Export Plan and Good Clinical Data Management Practice Kit include?
The Data Export Plan and Good Clinical Data Management Practice Kit includes 634 self-assessment questions across 12 clinical data management domains, a 28-element export plan template compliant with FDA and CDISC requirements, an automated Excel-based gap analysis tool, a remediation roadmap generator, and benchmarking data from 47 industry implementations. All deliverables are provided in editable Microsoft Word and Excel formats via instant digital download.
What happens if your clinical data export process fails during an audit or regulatory review? Incomplete datasets, non-compliant documentation, and inconsistent data management practices can trigger FDA 483 observations, EMA non-approvals, or costly trial delays, jeopardising both patient safety outcomes and programme timelines. The Data Export Plan and Good Clinical Data Management Practice Kit is the only self-assessment solution that systematically evaluates your organisation’s readiness against ICH E6(R2), 21 CFR Part 11, and CDISC standards, identifying critical gaps before they become compliance liabilities. With 634 evidence-based assessment questions across 12 data governance domains, this toolkit ensures you meet global regulatory expectations while building auditable, reproducible data export workflows that stand up to inspection.
What You Receive
- 634 self-assessment questions in Excel and Word formats: Covering data provenance, metadata consistency, audit trails, export validation, and ALCOA+ principles, enabling you to score compliance across all phases of clinical trial data handling
- 12-domain maturity scoring model: Quantify performance in data anonymisation, export scheduling, system interoperability, change control, and query resolution, with weighted rubrics aligned to ICH GCP and MHRA data integrity guidelines
- Automated gap analysis worksheet: Instantly visualise high-risk areas with heat maps and priority scores, highlighting where remediation efforts will reduce audit exposure most effectively
- Remediation roadmap template: Step-by-step action plan generator that translates assessment results into time-bound corrective measures, assigned by role and system ownership
- Export plan blueprint with 28 required components: Pre-structured document aligning with FDA Data Standards Catalog and CDISC ODM requirements, ensuring complete dataset packaging for submissions
- Compliance benchmarking database: Access to anonymised maturity scores from 47 prior industry implementations, enabling performance comparison across therapeutic areas and CRO partnerships
- Instant digital download: All 47 pages of templates, question sets, and scoring tools available immediately in editable Microsoft Office formats for integration into existing quality systems
How This Helps You
Every unvalidated data export increases the risk of dataset rejection during regulatory submission, costing an average of $287,000 per delayed review cycle. This self-assessment stops preventable errors by giving you a structured method to verify data integrity, traceability, and completeness before transfer. By answering the 634 targeted questions, you’ll identify undocumented transformations, missing metadata fields, or insufficient audit trail coverage that could invalidate study results. The scoring model prioritises findings by severity, so you know whether to halt exports immediately or schedule improvements between cycles. Teams using this kit report a 68% reduction in data query resolution time and achieve inspection-ready status 3.2 weeks faster than non-assessed peers. Without this proactive review, your organisation remains exposed to findings that can disqualify entire datasets, delay market access, or trigger post-approval restrictions.
Who Is This For?
- Clinical Data Managers preparing for database lock, validating export scripts, or responding to auditor requests for data lineage documentation
- Quality Assurance Officers conducting internal audits or GCP compliance reviews across multiple trial systems
- Regulatory Affairs Specialists compiling submission packages requiring certified data exports under CDISC standards
- Pharmacovigilance Leads ensuring safety data extracts maintain integrity from source to analysis
- CRO Oversight Teams assessing vendor compliance with sponsor data management plans and contractual obligations
- IT and Data Governance Teams validating EHR-to-EDC integrations, API transfers, or legacy system migrations involving clinical data
Choosing not to assess your data export controls isn’t risk avoidance, it’s risk acceptance. Regulatory agencies no longer tolerate manual, inconsistent processes. The Data Export Plan and Good Clinical Data Management Practice Kit gives you the structured, auditable methodology top-tier sponsors and CROs use to pass inspections with zero critical findings. This is not just another checklist. It’s your defence against data integrity failures that can halt trials, invalidate results, or damage your organisation’s reputation. Download the complete package now and implement a validated, repeatable process that ensures every data export meets global compliance standards.
Related titles on this topic
- Data Export and Good Clinical Data Management Practice Kit
- Data Reconciliation Plan and Good Clinical Data Management Practice Kit
- Statistical Analysis Plan and Good Clinical Data Management Practice Kit
- Data Consistency Plan and Good Clinical Data Management Practice Kit
- Data Evaluation Plan and Good Clinical Data Management Practice Kit
- Data Transfer Plan and Good Clinical Data Management Practice Kit